|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004358,
umls-concept:C0004561,
umls-concept:C0015576,
umls-concept:C0017262,
umls-concept:C0021758,
umls-concept:C0024141,
umls-concept:C0033268,
umls-concept:C0035820,
umls-concept:C0039194,
umls-concept:C0185117,
umls-concept:C0205177,
umls-concept:C0450254,
umls-concept:C0767393,
umls-concept:C1420816,
umls-concept:C1456820,
umls-concept:C2911684
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2007-6-25
|
|
pubmed:abstractText |
To determine whether B cell activating factor of the tumour necrosis factor family (BAFF) is involved in T cell-dependent B cell pathogenic autoantibody production in systemic lupus erythematosus (SLE).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Antinuclear,
http://linkedlifedata.com/resource/pubmed/chemical/Autoantibodies,
http://linkedlifedata.com/resource/pubmed/chemical/B-Cell Activating Factor,
http://linkedlifedata.com/resource/pubmed/chemical/B-Cell Activation Factor Receptor,
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/TNFRSF13B protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Transmembrane Activator and CAML...
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1462-0324
|
|
pubmed:author |
pubmed-author:AmanoHH,
pubmed-author:KobataTT,
pubmed-author:MitsuoAA,
pubmed-author:MorimotoSS,
pubmed-author:NakanoSS,
pubmed-author:NakiriYY,
pubmed-author:NozawaKK,
pubmed-author:SuzukiJJ,
pubmed-author:TakasakiYY,
pubmed-author:TamayamaYY,
pubmed-author:TokanoYY,
pubmed-author:WatanabeTT
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1083-6
|
|
pubmed:meshHeading |
pubmed-meshheading:17500077-Acute Disease,
pubmed-meshheading:17500077-Antibodies, Antinuclear,
pubmed-meshheading:17500077-Autoantibodies,
pubmed-meshheading:17500077-B-Cell Activating Factor,
pubmed-meshheading:17500077-B-Cell Activation Factor Receptor,
pubmed-meshheading:17500077-B-Lymphocytes,
pubmed-meshheading:17500077-Case-Control Studies,
pubmed-meshheading:17500077-Cells, Cultured,
pubmed-meshheading:17500077-DNA,
pubmed-meshheading:17500077-Flow Cytometry,
pubmed-meshheading:17500077-Humans,
pubmed-meshheading:17500077-Lupus Erythematosus, Systemic,
pubmed-meshheading:17500077-Lupus Nephritis,
pubmed-meshheading:17500077-Lymphocyte Activation,
pubmed-meshheading:17500077-RNA, Messenger,
pubmed-meshheading:17500077-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:17500077-T-Lymphocytes,
pubmed-meshheading:17500077-Transmembrane Activator and CAML Interactor Protein
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
|
|
pubmed:affiliation |
Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan. morimoto@med.juntendo.ac.jp
|
|
pubmed:publicationType |
Journal Article
|
